首页> 外文期刊>Cancer Imaging >The use of MRI in planning radiotherapy for gynaecological tumours
【24h】

The use of MRI in planning radiotherapy for gynaecological tumours

机译:MRI在计划妇科肿瘤放疗中的应用

获取原文
           

摘要

Parameters that significantly influence results in radiation treatment of gynaecological malignancies are mainly related to the tumour characteristics and the radiotherapy technique used. High-dose radiotherapy requires accurate localisation of the tumour volume and its relationship to surrounding normal tissues. For many years the standard technique used for irradiation of the pelvic area was the four-field box technique which offered the potential benefit of the lateral fields to shield the rectum and small bowel. However, this conventional technique was designed according to bony landmarks and offered limited information regarding the topography of the tumour and the flexion of the uterus which are influenced by the tumour burden and bladder and rectal filling. CT and MRI enable the visualisation of the cervix, uterus, vagina, iliac vessels and organs at risk, but MRI allows tumour depiction in all planes. In the early 1990s, several studies reported on the value of pelvic MRI in designing the lateral fields of the box technique. They demonstrated that conventional lateral portals would have resulted in a marginal tumour miss and incomplete coverage of the uterine fundus in more than 50% of cases, thus leading to the conclusion that if a box technique is used its design should be based on sagittal MRI. CT-based 3D planning systems are now routinely used in the vast majority of radiotherapy departments. Target volumes and organs at risk are delineated by the physician on each CT slice in order to conform the radiotherapy fields to the tumour volume. For several reasons, such as distortion and lack of electron density which is essential for dose calculation, the implementation of MRI into radiation treatment planning has its limitations. However, MRI can still be used if planning systems integrate tools for CT/MR image registration. There is little experience in the literature for gynaecological malignancies demonstrating that image fusion allows an improvement of the definition of the target and the organ at risk compared to CT alone. Only a few papers in the literature report on the use of CT/MR image registration in planning the external irradiation of gynaecological tumours. Most demonstrate feasibility, but they fail to quantify the improvement for volume definition compared to the use of CT alone. Finally, recent possibilities offered by MRI technology are promising in the area of brachytherapy planning as the full potential of individually defining and evaluating GTV and CTV based on tumour extent and anatomical structures is exploited.
机译:影响妇科恶性肿瘤放射治疗结果的参数主要与肿瘤特征和所用放射治疗技术有关。大剂量放射治疗需要准确定位肿瘤体积及其与周围正常组织的关系。多年来,用于照射骨盆区域的标准技术是四视野盒技术,该技术提供了侧视野可保护直肠和小肠的潜在好处。然而,这种传统技术是根据骨标志设计的,并且提供了关于肿瘤的地形和子宫弯曲的有限信息,这些信息受肿瘤负荷以及膀胱和直肠充盈的影响。 CT和MRI可以使处于危险中的子宫颈,子宫,阴道,血管和器官可视化,但是MRI可以在所有平面上描绘肿瘤。在1990年代初期,几项研究报道了骨盆MRI在设计Box技术的侧场方面的价值。他们证明,在超过50%的病例中,传统的侧门会导致边缘性肿瘤遗漏和子宫底覆盖不完全,因此得出结论,如果使用盒技术,其设计应基于矢状MRI。现在,绝大多数放疗科室通常使用基于CT的3D计划系统。医生在每个CT切片上划定目标体积和有风险的器官,以使放射治疗领域适应肿瘤体积。由于多种原因,例如畸变和缺乏电子密度,这对于剂量计算是必不可少的,因此在放射治疗计划中实施MRI有其局限性。但是,如果计划系统集成了用于CT / MR图像配准的工具,则MRI仍可以使用。妇科恶性肿瘤的文献报道表明,与单独使用CT相比,图像融合可以改善靶标和有风险的器官的定义。文献中只有少数论文报道了在计划妇科肿瘤的外部照射中使用CT / MR图像配准的情况。大多数显示出可行性,但与单独使用CT相比,他们无法量化体积定义的改善。最后,MRI技术提供的最新可能性在近距离放射治疗领域很有希望,因为可以充分利用基于肿瘤范围和解剖结构单独定义和评估GTV和CTV的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号